Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein D-like pseudogene 1 (HNRNPDLP1)

Target: HNRNPDLP1
Molecular classification: Other (pseudogene)

Overview

HNRNPDLP1, or heterogeneous nuclear ribonucleoprotein D-like pseudogene 1, is classified as a pseudogene. Pseudogenes are sequences in the genome that resemble protein-coding genes but lack the ability to code for a functional protein, typically due to mutations that disrupt gene expression or translation. HNRNPDLP1 shares sequence similarity with the functional HNRNPDL gene, which encodes an RNA-binding protein involved in mRNA metabolism, but HNRNPDLP1 itself does not encode a functional product and is not considered a therapeutic target[1][2].

Other names: HNRNPDLP1heterogeneous nuclear ribonucleoprotein D-like pseudogene 1

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein D-like pseudogene 1 (HNRNPDLP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein D-like pseudogene 1 (HNRNPDLP1).

Explore the full profile